S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

TERN Terns Pharmaceuticals Inc

5.90

-0.24 (-3.91%)

May 17 2024 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals (NASDAQ:TERN)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Terns Pharmaceuticals Charts.

Terns Pharmaceuticals Inc News

Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
Friday 17 May 2024 (7 hours ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 13 May 2024 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 May 2024 (5 days ago) • Edgar (US Regulatory)

Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
Monday 13 May 2024 (5 days ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Announces Leadership Changes
Wednesday 8 May 2024 (1 week ago) • GlobeNewswire Inc.

Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
Tuesday 7 May 2024 (1 week ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Friday 3 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
Monday 29 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
Wednesday 10 April 2024 (1 month ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
Monday 11 March 2024 (2 months ago) • GlobeNewswire Inc.

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.

More Terns Pharmaceuticals Inc News Articles

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions